\-\ Texto\\:\\ \ \(0\)\
\-\ ct\\ was\\ abnormal\ \(1\)\
\-\ well\\-circumscribed\\ lesion\\ off\\ inferior\\ aspect\\ right\\ lobe\\ of\\ the\\ liver\\ which\\ is\\ hyperattenuating\\ on\\ arterial\\ phases\\ imaging\\ and\\ becomes\\ isoattenuating\\ on\\ more\\ delayed\\ images\\.\\ \\ a\\ central\\ lower\\ attenuating\\ focus\\ can\\ be\\ seen\\ which\\ may\\ represent\\ the\\ \\"central\\ scar\\"\\.\ \(0\)\
\-\ note\\:\\ tc\\-99m\\ sulfur\\ colloid\\ scan\\ \\(not\\ included\\)\\ revealed\\ increased\\ uptake\\ in\\ this\\ region\\ in\\ relation\\ to\\ the\\ remainder\\ of\\ the\\ liver\\.\ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ fnh\\ \\(focal\\ nodular\\ hyperplasia\\)\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ fibrolamellar\\ hcc\ \(0\)\
\-\ hypervascular\\ metastatic\\ focus\ \(1\)\
\-\ 45\\ yo\\ woman\\ with\\ lower\\ abdominal\\ pain\ \(0\)\
\-\ although\\ a\\ hypoattenuating\\ central\\ scar\\ is\\ pathognomonic\\,\\ it\\ is\\ usually\\ seen\\ in\\ only\\ around\\ 50\\%\\ of\\ cases\\.\\ \\ the\\ central\\ scar\\ is\\ hypoattenuating\\ on\\ portal\\ venous\\ phase\\ imaging\\,\\ but\\ slowly\\ increases\\ in\\ attenuation\\ through\\ diffusion\\ of\\ the\\ contrast\\ agent\\ and\\ may\\ become\\ relatively\\ hyperattenuating\\ on\\ delayed\\ images\\.\ \(0\)\
\-\ a\\ large\\ percentage\\ of\\ lesions\\ may\\ show\\ one\\ of\\ more\\ atypical\\ features\\ \\(heterogenous\\ early\\ contrast\\ enhancement\\,\\ ill\\-defined\\ larger\\ lesions\\ on\\ arterial\\ scans\\,\\ hypoattenuating\\ portal\\ venous\\ phase\\ lesions\\ due\\ to\\ wash\\-out\\ effects\\,\\ compressed\\ parenchyma\\ surrounding\\ lesions\\ causing\\ a\\ hyperattenuating\\ rim\\ or\\ \\'pseudocapsule\\'\\)\\.\\ \\ in\\ these\\ cases\\,\\ confirmation\\ by\\ other\\ imaging\\ techniques\\ \\(tc\\-sulfur\\ colloid\\)\\ or\\ even\\ biopsy\\ is\\ indicated\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyperattenuating\\:\\ 0\\.2886171209432784\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.27306505517499885\ \(0\)\
\-\ scar\\:\\ 0\\.21866119031116543\ \(0\)\
\-\ central\\:\\ 0\\.20624506564283554\ \(0\)\
\-\ sulfur\\:\\ 0\\.19066428144726494\ \(0\)\
\-\ lesions\\:\\ 0\\.17737460689911477\ \(0\)\
\-\ colloid\\:\\ 0\\.16149351456447664\ \(0\)\
\-\ portal\\:\\ 0\\.1477803155112594\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.14078481176959165\ \(0\)\
\-\ phase\\:\\ 0\\.13213954491941204\ \(0\)\
\-\ focus\\:\\ 0\\.1308094661347356\ \(0\)\
\-\ arterial\\:\\ 0\\.1271714492366565\ \(0\)\
\-\ nodular\\:\\ 0\\.12297526416269618\ \(0\)\
\-\ imaging\\:\\ 0\\.12173234915902434\ \(0\)\
\-\ delayed\\:\\ 0\\.12084047120678178\ \(0\)\
\-\ on\\:\\ 0\\.11659654745009035\ \(0\)\
\-\ may\\:\\ 0\\.11656634005250309\ \(0\)\
\-\ isoattenuating\\:\\ 0\\.11409643769598539\ \(0\)\
\-\ venous\\:\\ 0\\.11025172156655354\ \(0\)\
\-\ liver\\:\\ 0\\.10652863063335696\ \(0\)\
\-\ is\\:\\ 0\\.10572497330091245\ \(0\)\
\-\ cases\\:\\ 0\\.10386610700836424\ \(0\)\
\-\ fnh\\:\\ 0\\.09713956545001907\ \(0\)\
\-\ in\\:\\ 0\\.09603903471603965\ \(0\)\
\-\ attenuating\\:\\ 0\\.09533214072363247\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.09533214072363247\ \(0\)\
\-\ percentage\\:\\ 0\\.09300604797869624\ \(0\)\
\-\ the\\:\\ 0\\.09243939260793953\ \(0\)\
\-\ focal\\:\\ 0\\.09236929925718813\ \(0\)\
\-\ of\\:\\ 0\\.090660125000009\ \(0\)\
\-\ hcc\\:\\ 0\\.08929138634742219\ \(0\)\
\-\ phases\\:\\ 0\\.08876051128241716\ \(0\)\
\-\ agent\\:\\ 0\\.08637972925462109\ \(0\)\
\-\ relation\\:\\ 0\\.085949992237456\ \(0\)\
\-\ more\\:\\ 0\\.08479514794779779\ \(0\)\
\-\ compressed\\:\\ 0\\.08362389949251978\ \(0\)\
\-\ confirmation\\:\\ 0\\.08259538623859909\ \(0\)\
\-\ techniques\\:\\ 0\\.08226921192323161\ \(0\)\
\-\ hypervascular\\:\\ 0\\.08163953657215649\ \(0\)\
\-\ increases\\:\\ 0\\.08103785622401612\ \(0\)\
\-\ effects\\:\\ 0\\.08018269320405273\ \(0\)\
\-\ lower\\:\\ 0\\.07891069791903628\ \(0\)\
\-\ slowly\\:\\ 0\\.07615133153154549\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.07594778515307353\ \(0\)\
\-\ contrast\\:\\ 0\\.07503134049461781\ \(0\)\
\-\ becomes\\:\\ 0\\.0738901577556297\ \(0\)\
\-\ heterogenous\\:\\ 0\\.07272687719954084\ \(0\)\
\-\ seen\\:\\ 0\\.07270144467460295\ \(0\)\
\-\ images\\:\\ 0\\.07143125900805439\ \(0\)\
\-\ which\\:\\ 0\\.07021800930410649\ \(0\)\
\-\ larger\\:\\ 0\\.06911451613340833\ \(0\)\
\-\ become\\:\\ 0\\.0685181386566752\ \(0\)\
\-\ remainder\\:\\ 0\\.0679469324206805\ \(0\)\
\-\ scans\\:\\ 0\\.06718569526510308\ \(0\)\
\-\ included\\:\\ 0\\.06676918304536902\ \(0\)\
\-\ diffusion\\:\\ 0\\.06503888433445827\ \(0\)\
\-\ even\\:\\ 0\\.06494894660094701\ \(0\)\
\-\ off\\:\\ 0\\.06450800926945324\ \(0\)\
\-\ represent\\:\\ 0\\.06425018091983153\ \(0\)\
\-\ indicated\\:\\ 0\\.06350491495087868\ \(0\)\
\-\ causing\\:\\ 0\\.06342458486884892\ \(0\)\
\-\ atypical\\:\\ 0\\.06334472871336437\ \(0\)\
\-\ relatively\\:\\ 0\\.06287523959980355\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06272229357593814\ \(0\)\
\-\ features\\:\\ 0\\.06212722724165716\ \(0\)\
\-\ 45\\:\\ 0\\.06191065335583316\ \(0\)\
\-\ around\\:\\ 0\\.06162717536977376\ \(0\)\
\-\ adenoma\\:\\ 0\\.061557223900939304\ \(0\)\
\-\ hepatic\\:\\ 0\\.06148763208134809\ \(0\)\
\-\ rim\\:\\ 0\\.06148763208134809\ \(0\)\
\-\ uptake\\:\\ 0\\.05937139747955585\ \(0\)\
\-\ attenuation\\:\\ 0\\.059077772536260245\ \(0\)\
\-\ note\\:\\ 0\\.05812456370078766\ \(0\)\
\-\ early\\:\\ 0\\.0556567358482818\ \(0\)\
\-\ biopsy\\:\\ 0\\.05412276646470222\ \(0\)\
\-\ 50\\:\\ 0\\.05392282813079217\ \(0\)\
\-\ or\\:\\ 0\\.05372126810377276\ \(0\)\
\-\ although\\:\\ 0\\.05256436072928344\ \(0\)\
\-\ inferior\\:\\ 0\\.05252850486965669\ \(0\)\
\-\ surrounding\\:\\ 0\\.05149475237468206\ \(0\)\
\-\ revealed\\:\\ 0\\.050627407941782616\ \(0\)\
\-\ aspect\\:\\ 0\\.049812310799402695\ \(0\)\
\-\ show\\:\\ 0\\.0490158705574182\ \(0\)\
\-\ usually\\:\\ 0\\.04860773172433776\ \(0\)\
\-\ yo\\:\\ 0\\.048237595170344164\ \(0\)\
\-\ only\\:\\ 0\\.048237595170344164\ \(0\)\
\-\ abnormal\\:\\ 0\\.04638785646739804\ \(0\)\
\-\ region\\:\\ 0\\.04618464962859407\ \(0\)\
\-\ through\\:\\ 0\\.04596238553602567\ \(0\)\
\-\ scan\\:\\ 0\\.0458089441298302\ \(0\)\
\-\ lobe\\:\\ 0\\.044620300927698184\ \(0\)\
\-\ enhancement\\:\\ 0\\.04444180718822833\ \(0\)\
\-\ due\\:\\ 0\\.04438282853677059\ \(0\)\
\-\ one\\:\\ 0\\.04420741900947279\ \(0\)\
\-\ these\\:\\ 0\\.04360152970607791\ \(0\)\
\-\ metastatic\\:\\ 0\\.04234684719712393\ \(0\)\
\-\ abdominal\\:\\ 0\\.042229218829705546\ \(0\)\
\-\ increased\\:\\ 0\\.041752506786853286\ \(0\)\
\-\ can\\:\\ 0\\.04051834229346007\ \(0\)\
\-\ woman\\:\\ 0\\.04021219336642765\ \(0\)\
\-\ other\\:\\ 0\\.0400973627384289\ \(0\)\
\-\ it\\:\\ 0\\.0395236761065986\ \(0\)\
\-\ large\\:\\ 0\\.038686978709296896\ \(0\)\
\-\ to\\:\\ 0\\.03860563072086897\ \(0\)\
\-\ but\\:\\ 0\\.038181389435194696\ \(0\)\
\-\ lesion\\:\\ 0\\.03701708719928891\ \(0\)\
\-\ by\\:\\ 0\\.03278863728721941\ \(0\)\
\-\ and\\:\\ 0\\.03190977448741654\ \(0\)\
\-\ be\\:\\ 0\\.03132176813020165\ \(0\)\
\-\ not\\:\\ 0\\.030481408852499087\ \(0\)\
\-\ ct\\:\\ 0\\.02939528311692383\ \(0\)\
\-\ pain\\:\\ 0\\.02762924790828029\ \(0\)\
\-\ was\\:\\ 0\\.026909100470029052\ \(0\)\
\-\ this\\:\\ 0\\.026531388354818882\ \(0\)\
\-\ right\\:\\ 0\\.025598928984461627\ \(0\)\
\-\ with\\:\\ 0\\.015119049067182231\ \(0\)\
